Michael J. Goldstein

  • ASSOCIATE PROFESSOR Surgery
Print ProfilePrint Profile

Certifications

  • American Board of Surgery

Clinical Focus

Education

  • MD, Temple University

  • Residency, Surgery (General)
    Columbia- Presbyterian Medical Center

  • Fellowship, Transplantation
    Columbia- Presbyterian Medical Center

Biography

    Dr. Goldstein is an Associate Professor of Surgery, Director of Renal and Pancreatic Transplantation at Mount Sinai Medical Center in New York, and Medical Director of the New York Organ Donor Network.

    With leadership positions in both organ donation and transplantation, Dr. Goldstein focuses on improving the clinical management of organ donors with the goal of maximizing the utilization of deceased donor organs for transplantation. He has directed his clinical efforts to increase patient access to transplantation and the successful transplantation of high-risk recipients. Previously, his efforts assisted the Weill-Cornell Medical College in growing deceased donor organ utilization by over 400%. He joined the Columbia University faculty as the Surgical Director of Pediatric Abdominal Transplantation to lead the growth of abdominal organ transplantation in children at the Morgan Stanley Children’s Hospital of New York. He has been invited to lecture on transplant growth and aggressive clinical style at many institutions. He has been an active consultant for the New York Organ Donor Network with positions on the Medical Advisory Board, Performance Improvement Committee, and the Kidney-Pancreas Subcommittee. In June 2009, Dr. Goldstein became the Medical Director of the New York Organ Donor Network to further champion efforts for improving organ donation. Outside of his Regional duties in New York, he serves as the Vice-Chair of the UNOS Organ Availability Committee and the Medical Directors Council of the Association of Organ Procurement Organizations.

    In addition to his active roles as an administrator and clinician, Dr. Goldstein is a prolific author of many manuscripts and editorials focusing on clinical transplantation outcomes, organ donor management, organ ischemia/preservation, and the changing nature and modernization of surgical education. He leads a team of researchers to improve the management of the deceased organ donor and enhance organ quality at the New York Organ Donor Network and with particular expertise in the topic of renal machine perfusion. Furthermore, he is one of the founding members of a National strategy for donor research.

    Dr. Goldstein has been an active participant in the HRSA Organ Transplantation Breakthrough Collaborative (OTBC) since its inception. He has been an invited speaker for the OTBC on Donor Service Area (DSA) challenges and successes, optimizing organ acceptance, transplanting organs with glomerulosclerosis, and regional disparities in access to organ transplantation. He has been a member of the Collaborative faculty for the Transplantation Growth and Management Collaborative and is co-Chair of the National Learning Congress for Organ Donation and Transplantation Community of Practice. He serves on the HRSA-sponsored Donor Management Task Force, as well as, the Transplant Center Task Force to develop new quality metrics for transplant centers.

    Dr. Goldstein is a Fellow of the American College of Surgeons, member of the American Society for Transplant Surgeons, American Society for Transplantation, and the Association of Academic Surgeons. He serves as a medical advisor to the National Kidney Foundation of Greater New York, as well as, numerous pharmaceutical and biotechnical companies for improving transplantation outcomes and patient care. Dr. Goldstein received his Bachelor of Arts in Neurobiology at the University of Pennsylvania and his Medical Doctorate at the Temple University School of Medicine. He completed both his post-doctoral residency fellowship in General Surgery and his abdominal transplantation fellowship at New York Presbyterian Hospital-Columbia University Medical Center.

    Dr. Goldstein In the Daily News

     

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Goldstein during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

  • Bristol-Myers Squibb; Organ Recovery Systems

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Icahn Medical Institute Floor 3 Room 3-61
1425 Madison Avenue
New York, NY 10029


Address

Icahn Medical Institute Floor L3 Room 3-61
1425 Madison Avenue
New York, NY 10029

Recanati/Miller Transplantation Institute

5 East 98th Street
12th Floor
New York, NY 10029

Tel: 212-659-8086
Get Directions